2',5'-oligoadenylate

interferon alpha 1 ; Homo sapiens







21 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 22357208 Expression, purification and characterization of the interferon-inducible, antiviral and tumour-suppressor protein, human RNase L. 2012 Mar 2
2 19749291 Introduction of 8-methyladenosine into 2', 5'-oligoadenylate (2-5A) 2'-terminus induces dramatic shift in binding site of RNase L. 2009 2
3 17263642 Inhibition of HIV type 1 replication in CD4+ and CD14+ cells purified from HIV type 1-infected individuals by the 2-5A agonist immunomodulator, 2-5A(N6B). 2007 Jan 2
4 17535916 Small-molecule activators of RNase L with broad-spectrum antiviral activity. 2007 Jun 5 1
5 16203993 A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. 2005 Oct 11 1
6 16241858 Mapping of the human RNASEL promoter and expression in cancer and normal cells. 2005 Oct 2
7 17200614 Induction of the interferon-inducible RNA-degrading enzyme, RNase L, by stress-inducing agents in the human cervical carcinoma cells. 2004 May 1
8 11152576 Caspase-dependent apoptosis by 2',5'-oligoadenylate activation of RNase L is enhanced by IFN-beta. 2000 Dec 2
9 10524248 Transcriptional induction of p69 2'-5'-oligoadenylate synthetase by interferon-alpha is stimulated by 12-O-tetradecanoyl phorbol-13-acetate through IRF/ISRE binding motifs. 1999 Sep 3 1
10 9525594 RNase L mediates the antiviral effect of interferon through a selective reduction in viral RNA during encephalomyocarditis virus infection. 1998 Apr 1
11 9660177 RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. 1998 Jun 1 2
12 9660242 Localization of a molecular form of interferon-regulated RNase L in the cytoskeleton. 1998 Jun 1
13 9260891 Protein kinase C is required for induction of 2',5'-oligoadenylate synthetases. 1997 Aug 1 1
14 8471593 Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta. 1993 Apr 1
15 1289408 Absence of biological effects of orally administered interferon-beta ser. 1992 Dec 2
16 1379287 Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression. 1992 May 1
17 2472992 Enhancement of interferon-induced 2-5 oligoadenylate synthetase activity by retinoic acid in human histiocytic lymphoma U937 cells and WISH cells. 1989 Mar 1
18 2523019 Interferon and (2'-5')oligoadenylate enhance the expression of low affinity receptors for IgE (Fc epsilon R2/CD23) on the human monoblast cell line U937. 1989 Mar 1
19 2466091 Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2',5'-oligoadenylate synthetase expression. 1988 Dec 1
20 2459906 In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia. 1987 Jul-Sep 1
21 3585079 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. 1987 Feb 2